Just in case you hadn't heard already, we're doing an hour-long webinar at 2 p.m. EST this afternoon on the regulatory challenges involved in designing an oncology clinical trial. Few issues are more central to drug development and I feel sure that this would be time well spent for anyone interested in clinical trial design.
We've assembled a group of experts in a range of time zones for today's session.
Our panel includes Scott Cormack, President & Chief Executive Officer, OncoGenex Technologies; Taylor Burtis, Vice President of Regulatory, Quality and Compliance, Tokai Pharmaceuticals; and Christoph Zanke, Global Strategic Head Oncology, AAIPharma. These panelists have decades of experience designing and conducting clinical trials of new cancer drugs. The webinar is sponsored by AAIPharma.
Please join us later today. You can register here. -- John Carroll